| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.6 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |